Centogene to participate in upcoming conferences in december

Cambridge, mass. and rostock, germany and berlin, dec. 01, 2022 (globe newswire) -- centogene n.v. (nasdaq: cntg), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced its conference schedule for december 2022. the company's pharma and cro business development team and diagnostics sales team will be attending events in the u.s. and japan. centogene invites attendees to schedule one-on-one meetings.
CNTG Ratings Summary
CNTG Quant Ranking